Pfizer restarts production at tornado-hit North Carolina plant, but drug supply will still be affected

Pfizer restarts production at tornado-hit North Carolina plant, but drug supply will still be affected


In this aerial image, damage is seen to a Pfizer pharmaceutical factory after a tornado hit the facility two days earlier, on July 21, 2023 in Rocky Mount, North Carolina.

Sean Rayford | Getty Images

Pfizer on Monday said it has restarted most production lines at a drug manufacturing plant that was severely damaged by a tornado two months ago, but added that some medicines from the facility may be in short supply until at least mid-2024.

In a statement, Pfizer stressed that it has only made the “first step toward full recovery” of its plant in Rocky Mount, North Carolina. The company expects the facility’s operations to fully resume by the end of the year.

The Rocky Mount plant supplies nearly 8% of all sterile injectable medicines used in U.S. hospitals, including anesthesia, analgesia, therapeutics, anti-infectives and neuromuscular blockers. The facility also manufactures about 25% of the company’s drugs in that category. 

Pfizer in August warned hospitals that some medicines could see supply disruptions. 

One injection from the plant was in short supply as of late last month, according to a database from the American Society of Health-System Pharmacists. It was a type of sodium chloride injection, which is used to replenish water and salt lost as a result of certain conditions. 

Pfizer on Monday said it has restarted production of about 13 medicines, which were prioritized based on “patient need and inventory levels.” The company did not specify which drugs those are.

Pfizer said it is also continuing to monitor emergency request orders for certain medicines manufactured at the Rocky Mount plant. The company implemented the emergency ordering process in August to manage the distribution of 12 drugs “in high medical need.”

Pfizer’s announcement comes as the U.S. is already facing an unprecedented shortage of medicine, ranging from ADHD pills to pain medicine to injectable cancer therapies. Those shortages are driven by manufacturing quality control issues and surges in demand, among other factors.



Source

Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition
Health

Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition

Weight loss syringes of the brands “Wegovy”, “Ozempic” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Novo […]

Read More
RFK Jr.’s firing of CDC vaccine panel undermines science, could threaten public health, experts say
Health

RFK Jr.’s firing of CDC vaccine panel undermines science, could threaten public health, experts say

U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. leaves the stage after discussing the findings of the Centers for Disease Control and Prevention’s (CDC) latest Autism and Developmental Disabilities Monitoring (ADDM) Network survey, at the Department of Health and Human Services in Washington, D.C., U.S., April 16, 2025. Elizabeth Frantz | Reuters […]

Read More
RFK Jr. removes all members of CDC panel advising U.S. on vaccines
Health

RFK Jr. removes all members of CDC panel advising U.S. on vaccines

U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. testifies before the Senate Committee on Appropriations hearing on the Department of Health and Human Services budget, on Capitol Hill in Washington, D.C., U.S., May 20, 2025. Ken Cedeno | Reuters Health and Human Services Secretary Robert F. Kennedy Jr. on Monday said he […]

Read More